SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

G- The "law" is the APA, the "regulation"

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Biobillionair Member Profile
 
Followed By 69
Posts 10,801
Boards Moderated 0
Alias Born 01/12/13
160x600 placeholder
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... "GlobeNewswire Inc." - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... "GlobeNewswire Inc." - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... "GlobeNewswire Inc." - 11/13/2017 6:00:00 AM
Amarin to Present at the Jefferies London Healthcare Conference "GlobeNewswire Inc." - 11/7/2017 6:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/1/2017 6:35:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2017 6:31:37 AM
Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 11/1/2017 5:30:00 AM
Amarin to Report Third Quarter 2017 Results and Host Conference Call on November 1, 2017 "GlobeNewswire Inc." - 10/25/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/6/2017 7:23:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:02 PM
Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada "GlobeNewswire Inc." - 9/25/2017 6:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 9/22/2017 1:08:41 PM
Amarin to Present at Cantor Global Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 4:30:00 PM
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer "GlobeNewswire Inc." - 9/13/2017 6:00:00 AM
Amarin to Present at Rodman & Renshaw’s Global Investment Conference "GlobeNewswire Inc." - 9/6/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 4:02:36 PM
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... "GlobeNewswire Inc." - 8/14/2017 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/2/2017 5:06:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2017 6:38:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 6:31:46 AM
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 8/2/2017 5:30:00 AM
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 "GlobeNewswire Inc." - 7/26/2017 4:30:00 PM
Biobillionair   Thursday, 10/05/17 06:38:48 PM
Re: HDGabor post# 115585
Post # of 118929 
G- The "law" is the APA, the "regulation" is the draft guidance related to SPA's and SPA communication, the evidence is the Ad Com video or transcript, you chose. For a bonus I can throw in law that regulates Ad Coms and case law that describes "arbitrary and capricious"....for example Judge Moss ruled the FDA would be arbitrary and capricious if the FDA would not rule on NCE. Instead the FDA was vindictive and delay NCE until last possible moment.

PS: I am the definition of vindictive, you can also find LB as a close second place followed by the third place going to Epi.

PSS: If you can't respond in an intelligent manner I suggest you try and insult me...again. You'll find my mental stability fairs quite well under significant pressure...this is my professional opinion.

PSSS: If Amarin loses ITC case and FDA doesn't take action against respondents, Amarin's attorney's will show you further law regarding APA, regulation, draft guidances, guidance, and ANCHOR damages, I promise. The last email I received from JT was clear Amarin stakeholders where going to be priority...then came ITC action.

BB


Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist